Many people do not realize that COVID-19 can affect more than a patient’s lungs. As more and more research on the affects of COVID-19 disseminates, we are finding out that the disease also has the potential to cause long term…
Executive Summary Multiple-of-Medicare (“MoM”) repricing is a popular and common cost containment strategy used by many plans and repricing companies for dialysis claims repricing. Renalogic has intentionally chosen to stay away from MoM methods because of the high risk of…
The central mission of Renalogic has always been to drive positive change for kidney disease and help members thrive while living with chronic conditions. These values hold even more now with our member’s lives so significantly impacted by the COVID-19…
Health Benefits Risk Management at the Intersection of Monopoly and Intensive Regulation The dialysis sector is an intensified microcosm of the American health care system, and that’s bad for self-insured plans in particular. On the one hand, the dialysis marketplace…
Treatment costs for chronic kidney disease (CKD) and end-stage renal disease (ESRD) are high and rising dramatically, putting self-funded health plans at risk. Meanwhile, most health plan members with moderate kidney damage are unaware they have it until it has…
There are two times a year where I really feel the urge to make a fresh start; to try anew to improve myself. During Fall, you have the back-to-school season, and then, of course, there's the New Year. I love…
Here we go! The countdown for 2017 is on! Once the ball drops, you might say, it's time to get back on track and focus on that diet you set aside in November, or get back to reinventing yourself. But,…
Renalogic - All Rights Reserved 2020
